| INKDX | RGACX | INKDX / RGACX | |
| Total Expense Ratio | 0.71 | 0.93 | 76% |
| Annual Report Gross Expense Ratio | 0.71 | 0.93 | 76% |
| Fund Existence | 3 years | 24 years | - |
| Gain YTD | -42.044 | 5.397 | -779% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.27B | 357B | 1% |
| Annual Yield % from dividends | N/A | 0.00 | - |
| Returns for 1 year | -42.04 | 0.93 | -4,534% |
| Returns for 3 years | -33.32 | 33.65 | -99% |
| Returns for 5 years | N/A | 10.91 | - |
| Returns for 10 years | N/A | 94.42 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PLTW | 16.87 | 0.16 | +0.96% |
| Roundhill PLTR WeeklyPay ETF | |||
| PKB | 100.29 | 0.59 | +0.59% |
| Invesco Building & Construction ETF | |||
| PGX | 10.73 | -0.01 | -0.09% |
| Invesco Preferred ETF | |||
| TIIV | 30.54 | -0.04 | -0.12% |
| AAM Todd International Intrinsic Val ETF | |||
| IBBQ | 32.10 | -0.60 | -1.84% |
| Invesco Nasdaq Biotechnology ETF | |||